Rasch progrediente Demenz: Enzephalitis oder Enzephalopathie?

G. Ellrichmann; C. Lukas; W. J. Schulz-Schaeffer; C. Börnke

doi:10.1055/s-0033-1343301

Klinische Neurophysiologie, Table of Contents

Klinische Neurophysiologie 2013; 44(03): 213-218
DOI: 10.1055/s-0033-1343301

Der besondere Fall

Rasch progrediente Demenz: Enzephalitis oder Enzephalopathie?

Rapidly Progressive Dementia: Inflammation or Degeneration?

G. Ellrichmann

¹Department of Neurology, St. Josef Hospital, Ruhr-University Bochum

,

C. Lukas

²Department of Radiology, St. Josef Hospital, Ruhr-University Bochum

,

W. J. Schulz-Schaeffer

³National Reference Centre for Transmissible Spongiform Encephalopathies, Department of Neuropathology, University Medical Center Goettingen, Germany

,

C. Börnke

¹Department of Neurology, St. Josef Hospital, Ruhr-University Bochum

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Schulz-Schaeffer WJ, Tschöke S, Kranefuss N et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000; 156: 51-56
2 Edler J, Mollenhauer B, Heinemann U et al. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Disord 2009; 24: 350-356
3 Voltz R, Blaes F, Rauer S, Weller M. Paraneoplastisches Syndrom. Leitlinien für Diagnostik und Therapie in der Neurologie. 4.. überarbeitete Auflage, Stuttgart: Thieme; 2008
4 Sakai K. Recent advances in paraneoplastic encephalomyeloneuronopathy. Nihon Rinsho 1994; 52: 3006-3012
5 Graus F, Keime-Guibert F, Rene R et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-1148
6 Dalmau J, Graus F, Rosenblum MK et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992; 71: 59-72
7 Chitravas N, Jung RS, Kofskey DM et al. Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease. Ann Neurol 2011; 70: 437-444
8 Leitlinien für Diagnostik und Therapie in der Neurologie. 4.. überarbeitete Auflage, Stuttgart: Thieme; 2008
9 Parchi P, Giese A, Capellari S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233
10 Castellani RJ, Colucci M, Xie Z et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-442
11 Collins SJ, Sanchez-Juan P, Masters CL et al. Determinants of diagnostic investigation sensivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129: 2278-2287
12 Satoh K, Shirabe S, Tsujino A et al. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2007; 24: 207-212
13 Tschampa HJ, Kallenberg K, Meissner B et al. Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. Am J Neurorad 2007; 28: 1114-1118
14 Galanaud D, Dormont D, Haik S et al. Differences of apparant diffusion coefficient values in patients with Creutzfeldt-Jakob disease according tot he codon 129 genotype. Am J Neuroradiol 2008; 29: E57
15 Meissner B, Kallenberg K, Sanchez-Juan P et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. Am J Neurorad 2008; 29: 1519-1524
16 Zerr I, Kallenberg K, Summers DM et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-2668
17 Foote M, Zhou Y. 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 2012; 3: 152-164
18 Zerr I, Pocchiari M, Collins S et al. Analysis of EEF and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-815
19 Zeidler M, Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 analysis. Neurology 2004; 63: 410-411
20 Chang CC, Eggers SD, Johnson JK et al. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2007; 109: 54-57
21 Geschwind MD, Tan KM, Lennon VA et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008; 65: 1341-1346
22 Schott JM, Reiniger L, Thom M et al. Brain biopsy in dementia: clinical indications and diagnostic approach. Acta Neuropathol 2010; 120: 327-341
23 Wemheuer WM, Benestad SL, Wrede A et al. Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol 2009; 175: 2566-2573
24 Interdisziplinärer Experten-Konsens im Arbeitskreis „Krankenhaus- & Praxishygiene“ der AWMF. AWMF Leitlinie 029/025: Prophylaxe der Creutzfeldt-Jakob-Erkrankung in Krankenhaus und Praxis. www.awmf.org/uploads/tx_szleitlinien/029-025l_S1_Prophylaxe_Creutzfeld-Jakob-Erkrankung.pdf (Stand 01/2012)